Authors:
BECK JF
BUCHHOLZ F
ULRICH WR
BOER R
SANDERS KH
NIETHAMMER D
GEKELER V
Citation: Jf. Beck et al., RHODAMINE-123 EFFLUX MODULATION IN THE PRESENCE OF LOW OR HIGH SERUM FROM CD56(-CELLS OR CD34(+) LEUKEMIC BLASTS BY B9309-068, A NEWLY DESIGNED PYRIDINE DERIVATIVE() HEMATOPOIETIC), Cancer letters, 129(2), 1998, pp. 157-163
Authors:
ISE W
BAUR I
HEUSER M
LOFFLER S
STEINHILBER W
ULRICH WR
WIESBACHER M
Citation: W. Ise et al., NEW METHOD FOR THE QUANTIFICATION OF HOST-CELL PROTEIN IN RECOMBINANTLUNG SURFACTANT PROTEIN SP-C, The FASEB journal, 11(9), 1997, pp. 613-613
Authors:
BOER R
GEKELER V
ULRICH WR
ZIMMERMANN P
ISE W
SCHODL A
HAAS S
Citation: R. Boer et al., MODULATION OF P-GLYCOPROTEIN MEDIATED DRUG ACCUMULATION IN MULTIDRUG-RESISTANT CCRF VCR-1000 CELLS BY CHEMOSENSITIZERS, European journal of cancer, 32A(5), 1996, pp. 857-861
Authors:
ELTZE M
BOER R
SANDERS KH
PRUSSE W
ULRICH WR
Citation: M. Eltze et al., B8805-033 - AN EXTREMELY ALPHA(1A)-ADRENOCEPTOR-SELECTIVE ANTAGONIST, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 35-35
Authors:
BOER R
ULRICH WR
HAAS S
BORCHERS C
GEKELER V
BOSS H
PRZYBYLSKI M
SCHODL A
Citation: R. Boer et al., INTERACTION OF CYTOSTATICS AND CHEMOSENSITIZERS WITH THE DEXNIGULDIPINE BINDING-SITE ON P-GLYCOPROTEIN, European journal of pharmacology, 295(2-3), 1996, pp. 253-260
Authors:
BOER R
DICHTL M
BORCHERS C
ULRICH WR
MARECEK JF
PRESTWICH GD
GLOSSMANN H
STRIESSNIG J
Citation: R. Boer et al., REVERSIBLE LABELING OF A CHEMOSENSITIZER BINDING DOMAIN OF P-GLYCOPROTEIN WITH A NOVEL 1,4-DIHYDROPYRIDINE DRUG TRANSPORT INHIBITOR, Biochemistry, 35(5), 1996, pp. 1387-1396
Authors:
BORCHERS C
ULRICH WR
KLEMM K
ISE W
GEKELER V
HAAS S
SCHODL A
CONRAD J
PRZYBYLSKI M
BOER R
Citation: C. Borchers et al., B9209-005, AN AZIDO DERIVATIVE OF THE CHEMOSENSITIZER DEXNIGULDIPINE-HCL, PHOTOLABELS P-GLYCOPROTEIN, Molecular pharmacology, 48(1), 1995, pp. 21-29
Authors:
GEKELER V
ISE W
SANDERS KH
ULRICH WR
BECK J
Citation: V. Gekeler et al., THE LEUKOTRIENE LTD(4) RECEPTOR ANTAGONIST MK571 SPECIFICALLY MODULATES MRP ASSOCIATED MULTIDRUG-RESISTANCE, Biochemical and biophysical research communications, 208(1), 1995, pp. 345-352